Thermo Fisher Scientific (TMO)
EBITDA Growth
-11.61%
Quarterly · Period ending:
TMO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-11.61%period ending
Latest reported-11.61%period ending
TMO Quarterly EBITDA YoY % (35.02% → -11.61%)
Year-over-year change
High-resolution chart · PNG
TMO ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -11.609% | |
| 3.7884% | |
| -0.4566% | |
| 4.824% | |
| -2.4776% | |
| -6.0128% | |
| -5.7051% | |
| 1.4886% | |
| -3.4872% | |
| 14.0176% | |
| 10.5075% | |
| 4.4575% | |
| 15.2757% | |
| -9.9966% | |
| -28.6563% | |
| 6.9475% | |
| -10.8228% | |
| 2.5451% | |
| 1.0289% | |
| -25.7002% | |
| -1.4137% | |
| 44.0428% | |
| 128.9921% | |
| 107.4032% | |
| 90.3267% | |
| -8.4382% | |
| -2.114% | |
| 0.8037% | |
| 1.6938% | |
| 38.6555% | |
| 13.7755% | |
| 11.7025% | |
| 33.0156% | |
| 25.0606% | |
| 24.4106% | |
| 24.0652% | |
| 18.4562% | |
| 9.5369% | |
| 8.1495% | |
| 13.2228% | |
| -2.228% | |
| 10.0468% | |
| 12.4628% | |
| 2.6063% | |
| -1.0919% | |
| 1.1234% | |
| 4.3143% | |
| 55.4821% | |
| 48.3871% | |
| 70.9569% | |
| 32.0371% | |
| 4.7884% | |
| 12.7928% | |
| -3.8549% | |
| 7.6885% | |
| 8.2831% | |
| 10.5012% | |
| 24.8281% | |
| 19.6048% | |
| 16.1113% | |
| 11.4362% | |
| 5.1893% | |
| 7.4643% | |
| 2.1268% | |
| 3.6472% | |
| 3.114% | |
| 22.6722% | |
| -3.7588% | |
| -5.3012% | |
| -13.0766% | |
| -21.5341% | |
| 7.5876% | |
| 10.5684% | |
| 19.6624% | |
| 28.3043% | |
| 172.2056% | |
| 275.1364% | |
| 277.7031% | |
| 254.0661% | |
| 40.197% | |
| 8.6533% | |
| 36.218% | |
| 41.3065% | |
| 42.8659% | |
| 36.5238% | |
| 11.8067% | |
| 8.8452% | |
| 0.4132% | |
| 31.9428% | |
| 21.6651% | |
| 15.1126% | |
| 22.9338% | |
| -6.4949% | |
| 42.0344% | |
| 2.9822% | |
| 14.9615% | |
| 2.9098% | |
| -29.3826% | |
| -20.1047% | |
| -1.4562% |